Walleye Trading LLC Atara Biotherapeutics, Inc. Transaction History

Walleye Trading LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$14.0 - $20.72 $147,294 - $217,995	-10,521 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.67 - $26.23 $133,301 - $275,965	10,521 New	10,521 $207,000
Q1 2020 May 15, 2020	SELL	$5.69 - $17.78 $36,569 - $114,272	-6,427 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$10.89 - $16.79 $27,421 - $42,277	-2,518 Reduced 28.15%	6,427 $106,000
Q3 2019 Nov 14, 2019	BUY	$12.03 - $19.94 $79,939 - $132,501	6,645 Added 288.91%	8,945 $126,000

Q2 2019 Aug 14, 2019	BUY	$19.05 - $41.04 $43,815 - $94,392	2,300 New	2,300 $46,000
Q3 2017 Nov 14, 2017	SELL	$13.25 - $17.05 $9,275 - $11,935	-700 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	700	700 $10,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $710M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.